Clinical Trial Update: Investigation of Cycloserine as a Smoking Cessation Treatment [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1 study evaluating cycloserine as a treatment to help people quit smoking (nicotine dependence).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence

Drugs mentioned

• Cycloserine (cycloserine)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Nicotine Addiction | Phase 1 | Status: COMPLETED